The development of the Enterprise is closely connected with the key periods of the country's history.
In 1943, in wartime conditions, the plant's staff was able to organize within a short time the production of insulin, thyroidin, and a year later - penicillin, necessary for the needs of the front and homefront. In the postwar years, Moscow Endocrine Plant was a leader in production of active pharmaceutical ingredients and medicines and manufactured innovative dosage forms. After the collapse of the USSR, when the production of a number of medicines including controlled drugs and substances remained outside the Russian Federation, the Enterprise organized from scratch the production of strategically important medicines necessary for anaesthesis of palliative patients and surgeries.
From the moment of its foundation to the present day, Moscow Endocrine Plant has been an instrument of state policy to ensure the medicine safety of the country.
Today the FSUE Moscow Endocrine Plant (ENDOPHARM) is under the jurisdiction of the Ministry of Industry and Trade of Russia and includes 3 production sites equipped with modern high-technology equipment, its own subdivisions for scientific and pharmaceutical development, introduction and marketing authorization of drugs, a vivarium, an accredited testing laboratory.
The Enterprise produces about 100 titles of medicines in a wide range of dosage forms that are in demand in various fields of medicine, most of which are included in the list of vital and essential medicines.
In the difficult conditions of the previous year the FSUE Moscow Endocrine Plant, by the order of the Government of the Russian Federation and the Ministry of Industry and Trade of Russia implemented the project to ensure the safety of citizens of the Russian Federation in terms of organization of the production of disposable medical masks. The production of state and pharmacopoeial reference standards has been established, work on the organization of large-scale production of active pharmaceutical ingredients continues. The Enterprise carries out the import of unregistered drug products required by citizens for medical reasons.
In the next cycle of its development ENDOPHARM increases production volumes and a portfolio of manufactured drugs, expands the list of competencies.
The dynamic development of the Enterprise is due to the social significance of the performed tasks, high requirements for the effectiveness of scientific research, production processes and personnel qualifications. Compliance with this requirement is ensured thanks to the culture of production and traditions of quality laid down by previous generations of workers, as well as the cooperation of the Moscow Endocrine Plant with leading research and educational organizations of the country, professional medical communities, socially oriented non-profit organizations, federal executive authorities and executive authorities of the constituent entities of the Russian Federation.
Congratulations on the 78th anniversary of the founding of the Enterprise to all employees and veterans of each ENDOPHARM unit, who, with pride and a sense of responsibility, have contributed and still contribute to the development of the Moscow Endocrine Plant.
The ENDOPHARM team would like to thank the contractors and strategic partners for the fruitful cooperation and incoming congratulations!
Comment type is not specified in the component properties.